Cargando…

The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy

Only few applications are currently dealing with personalized adverse drug reactions (ADRs) prediction in case of polypharmacy. The study aimed to develop a patient-tailored ADR web application, considering characteristics from 734 drugs and relevant patient related factors. The application was desi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valeanu, Andrei, Damian, Cristian, Marineci, Cristina Daniela, Negres, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293306/ https://www.ncbi.nlm.nih.gov/pubmed/32533040 http://dx.doi.org/10.1038/s41598-020-66611-8

Ejemplares similares

Author Correction: The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy
por: Valeanu, Andrei, et al.
Publicado: (2021)

Adverse drug reactions and polypharmacy in cardiac patients
por: Mugoša, Snežana, et al.
Publicado: (2012)

Adverse drug reactions in the era of multi-morbidity and polypharmacy
por: Birriel, T. Javier, et al.
Publicado: (2015)

Ranking Adverse Drug Reactions With Crowdsourcing
por: Gottlieb, Assaf, et al.
Publicado: (2015)

Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review
por: Rodrigues, Maria Cristina Soares, et al.
Publicado: (2016)

Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study
por: Sato, Izumi, et al.
Publicado: (2013)

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions
por: Osanlou, Rostam, et al.
Publicado: (2022)

Indirect and Direct 65+ Patient Reporting of Non-Steroidal Anti-Inflammatory Drug-Induced Adverse Drug Reactions as a Source of Information on Polypharmacy and Polypharmacy-Related Risk
por: Sienkiewicz, Kamila, et al.
Publicado: (2023)

Network-Based Assessment of Adverse Drug Reaction Risk in Polypharmacy Using High-Throughput Screening Data
por: de Anda-Jáuregui, Guillermo, et al.
Publicado: (2019)

Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric ward
por: Noorda, Nikki M. F., et al.
Publicado: (2022)

Antipsychotic polypharmacy and adverse drug reactions among adults in a London mental health service, 2008–2018
por: Yang, Justin C., et al.
Publicado: (2023)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
por: Ayani, Nobutaka, et al.
Publicado: (2021)

Individual Pharmacotherapy Management (IPM)—IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy
por: Wolf, Ursula, et al.
Publicado: (2022)

Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
por: Negishi, Akio, et al.
Publicado: (2020)

Effects of Polypharmacy on Adverse Drug Reactions among Geriatric Outpatients at a Tertiary Care Hospital in Karachi: A Prospective Cohort Study
por: Ahmed, Bilal, et al.
Publicado: (2014)

In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity
por: Andrei, Corina, et al.
Publicado: (2022)

Using INTERCheck(®) to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
por: Martocchia, Antonio, et al.
Publicado: (2020)

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study
por: Hanlon, Peter, et al.
Publicado: (2018)

Tailoring adverse drug event surveillance to the paediatric inpatient
por: Long, Andrea L, et al.
Publicado: (2010)

Polypharmacy and adverse outcomes after hip fracture surgery
por: Härstedt, Maria, et al.
Publicado: (2016)

Adverse Outcomes, Polysubstance Use, and Polypharmacy in Older Veterans
por: Byers, Amy
Publicado: (2020)

POLYPHARMACY VERSUS DRUG COMBINATIONS
por: Agarwal, A.K.
Publicado: (1991)

Focus on headache as an adverse reaction to drugs
por: Ferrari, Anna, et al.
Publicado: (2009)

Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database
por: Abe, Junko, et al.
Publicado: (2017)

Drug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing
por: Moore, Bret A., et al.
Publicado: (2017)

Adverse Drug Reactions
por: Turner, Paul
Publicado: (1988)

Adverse Drug Reactions
por: Criado, Paulo Ricardo
Publicado: (2016)

Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy
por: Al Rihani, Sweilem B., et al.
Publicado: (2020)

Adverse drug reactions in hospitalized Colombian children
por: de las Salas, Roxana, et al.
Publicado: (2016)

Mining drug–target and drug–adverse drug reaction databases to identify target–adverse drug reaction relationships
por: Galletti, Cristiano, et al.
Publicado: (2021)

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation
por: Chen, Nemin, et al.
Publicado: (2020)

Textbook of adverse drug reactions /
Publicado: (1977)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Adverse drug reactions in the elderly
por: Brahma, Dhriti K., et al.
Publicado: (2013)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

The Detection of Adverse Drug Reactions
por: Crooks, James
Publicado: (1977)

Textbook of Adverse Drug Reactions
por: George, Charles F.
Publicado: (1992)

The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes
por: Höhn, Andreas, et al.
Publicado: (2021)

New FDA approved antibacterial drugs: 2015-2017
por: Andrei, Stefan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r4pjudcfi4d9p3vbltcp7imas3